Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer

Efficacy findings from a randomized phase III trial of capecitabine plus oxaliplatin versus bolus 5-FU/LV for stage III colon cancer (NO16968): Impact of age on disease-free survival (DFS).

(2017) D. G. Haller et al.   JOURNAL OF CLINICAL ONCOLOGY

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer

(2015) Toshiaki Watanabe et al.   International Journal of Clinical Oncology

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

(2014) M. Yoshida et al.   ANNALS OF ONCOLOGY

Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205

(2014) Yasuhiro Shimada et al.   EUROPEAN JOURNAL OF CANCER

Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor

(2014) Niek Hugen et al.   INTERNATIONAL JOURNAL OF CANCER

Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study

(2013) Se Hyun Kim et al.   ANNALS OF SURGICAL ONCOLOGY

pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited

(2013) P. Snaebjornsson et al.   INTERNATIONAL JOURNAL OF CANCER

Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon

(2011) Soichiro Ishihara et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

From Chemotherapy to Targeted Therapy in Adjuvant Treatment for Stage III Colon Cancer

(2011) Aimery de Gramont et al.   SEMINARS IN ONCOLOGY